During the past decade, Dialysezentrum Barmbek conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dialysezentrum Barmbek" are "Hyperphosphatemia" (1 trials) and "Kidney Diseases" (1 trials). Many other conditions were trialed in "Dialysezentrum Barmbek" in a lesser frequency.

Most popular intervention types in "Dialysezentrum Barmbek" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lanthanum carbonate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dialysezentrum Barmbek" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dialysezentrum Barmbek". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dialysezentrum Barmbek, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dialysezentrum Barmbek, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".